Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue

Ebrahim S. Delpassand, David J. Yang, Sidney Wallace, Abdallah Cherif, Syed M. Quadri, Janet Price, Angela Joubert, Tomio Inoue, Donald A. Podoloff

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

This study was aimed at developing a hydrophilic diethylenetriaminepentaacetic acid-tamoxifen (DTPA-Tam) analogue for use in imaging estrogen receptor positive (ER+) lesions. In rat uterine cytosol, the IC50 of DTPA-Tam conjugate was 1 μM and of tamoxifen, 2 μM. Biodistribution, autoradiography, and radionuclide imaging of 111In-DTPA-Tam in breast-tumor-bearing rats showed that tumor-to-tissue ratios increased steadily between 30 min and 48 h. The in vivo response of MCF-7 breast cancer xenografts to tamoxifen and DTPA-Tam in nude mice demonstrated that DTPA-Tam could reduce tumor growth rate. These results indicate that DTPA-Tam, a new hydrophilic ER+ ligand, might be useful in diagnosing ER+ lesions.

Original languageEnglish (US)
Pages (from-to)553-559
Number of pages7
JournalJournal of Pharmaceutical Sciences
Volume85
Issue number6
DOIs
StatePublished - Jun 1996

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue'. Together they form a unique fingerprint.

Cite this